SB-001

N/A

Report date: 2024/12/11 14:00:00

Base Information

Drug NameSB-001
Drug Alias NameSB-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionLatent-transforming growth factor beta-binding protein 4 inhibitors
TargetsLatent-transforming growth factor beta-binding protein 4
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSolid BiosciencesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesSolid BiosciencesNorthwestern University
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A